Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CD40 expression in epidermal tumors

J Viac1, D Schmitt, A Claudy

  • 1INSERM U346 and Clinique Dermatologique, Hôpital E. Herriot, Lyon, France.

Anticancer Research
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidence of human papillomavirus type 33 in premalignant and malignant skin lesions from organ transplant recipients.

International journal of oncology·2011
Same author

Omenn syndrome due to mutation of the RAG2 gene.

Journal of the European Academy of Dermatology and Venereology : JEADV·2009
Same author

Nickel-induced systemic allergic dermatitis from a sacral neurostimulator.

Contact dermatitis·2008
Same author

[Efalizumab-induced pancytopenia].

Annales de dermatologie et de venereologie·2008
Same author

Retinoids for the management of dermatological complications of organ transplantation.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2007
Same author

Subcutaneous dermatofibrosarcoma protuberans masquerading as a cyst.

Journal of the European Academy of Dermatology and Venereology : JEADV·2007
Same journal

Corrigendum.

Anticancer research·2026
Same journal

Geographic Variation in Stage at Diagnosis of Skin Cancer in the United States: A National Cancer Database Analysis.

Anticancer research·2026
Same journal

Anti-tumor Effects of Loureirin A Treatment in Colorectal Cancer Cells <i>via</i> Inhibition of AKT Phosphorylation.

Anticancer research·2026
Same journal

Bayesian Analysis to Refine East Asian Subgroup Estimates in the CLEAR Trial (Lenvatinib Plus Pembrolizumab <i>vs</i>. Sunitinib) for Advanced Renal Cell Carcinoma.

Anticancer research·2026
Same journal

Pulsed Electromagnetic Field Increases Doxorubicin-induced Mitotic Slippage in MDA-MB-231 Breast Cancer Cells.

Anticancer research·2026
Same journal

Geographic Disparities in Socioeconomic Factors and Advanced-stage Presentation in Rectosigmoid Cancer: A National Cancer Database Analysis.

Anticancer research·2026
See all related articles

CD40 antigen expression is lost in skin tumors like basal cell carcinoma and squamous cell carcinoma. This loss may help tumors evade T cell attacks, impacting immune responses in skin cancer.

Area of Science:

  • Immunodermatology
  • Oncology
  • Cellular Biology

Background:

  • CD40 antigen, crucial for cell-cell interactions, is expressed on various cells, including skin keratinocytes.
  • Keratinocyte CD40 expression is implicated in amplifying inflammatory responses within the skin.
  • Activated T cells express CD40 ligand, facilitating interaction with CD40-expressing cells.

Purpose of the Study:

  • To investigate CD40 antigen expression in epidermal tumors.
  • To correlate CD40 expression with T cell infiltrates in skin lesions.
  • To understand the role of CD40 in tumor immune evasion mechanisms.

Main Methods:

  • Analysis of CD40 antigen expression in a series of epidermal tumors.
  • Examination of T cell infiltrates within tumor microenvironments.

Related Experiment Videos

  • Correlation studies between CD40 expression levels and tumor type/grade.

    • Main Results:

    • Significant down-regulation or loss of CD40 antigen observed in basal cell carcinoma and squamous cell carcinoma tumor cells.
    • Moderate to discrete CD40 reactivity noted in keratinocytes of benign viral-induced lesions.
    • Strong CD40 expression detected on endothelial cells, infiltrating cells, and dendritic cells, particularly in benign lesions.

    Conclusions:

    • The lack of CD40 expression by tumor cells may represent a mechanism for immune escape from CD40 ligand-expressing T cells.
    • CD40 expression patterns differ significantly between benign and malignant epidermal lesions.
    • CD40-mediated interactions between T cells and keratinocytes are observable in benign lesions, suggesting a role in immune surveillance.